1204 related articles for article (PubMed ID: 9825931)
1. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
[TBL] [Abstract][Full Text] [Related]
2. E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.
Matsui-Inohara H; Uematsu H; Narita T; Satoh K; Yonezawa H; Kuroda K; Ito T; Yoneda S; Kawarai T; Sugiya H; Watanabe H; Senpuku H
Exp Biol Med (Maywood); 2009 Dec; 234(12):1525-36. PubMed ID: 19934373
[TBL] [Abstract][Full Text] [Related]
3. Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background.
Cha S; Nagashima H; Brown VB; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 2002 May; 46(5):1390-8. PubMed ID: 12115247
[TBL] [Abstract][Full Text] [Related]
4. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland.
Jonsson MV; Delaleu N; Brokstad KA; Berggreen E; Skarstein K
Arthritis Rheum; 2006 Jul; 54(7):2300-5. PubMed ID: 16802370
[TBL] [Abstract][Full Text] [Related]
5. A novel NOD-derived murine model of primary Sjögren's syndrome.
Robinson CP; Yamachika S; Bounous DI; Brayer J; Jonsson R; Holmdahl R; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 1998 Jan; 41(1):150-6. PubMed ID: 9433880
[TBL] [Abstract][Full Text] [Related]
6. Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjögren's syndrome.
Yamachika S; Nanni JM; Nguyen KH; Garces L; Lowry JM; Robinson CP; Brayer J; Oxford GE; da Silveira A; Kerr M; Peck AB; Humphreys-Beher MG
J Rheumatol; 1998 Dec; 25(12):2371-80. PubMed ID: 9858432
[TBL] [Abstract][Full Text] [Related]
7. Modified aquaporin 5 expression and distribution in submandibular glands from NOD mice displaying autoimmune exocrinopathy.
Soyfoo MS; De Vriese C; Debaix H; Martin-Martinez MD; Mathieu C; Devuyst O; Steinfeld SD; Delporte C
Arthritis Rheum; 2007 Aug; 56(8):2566-74. PubMed ID: 17665453
[TBL] [Abstract][Full Text] [Related]
8. The protein kinase C system in focal adenitis of the lacrimal gland in the non-obese diabetic mouse model for Sjögren's syndrome.
Tensing EK; Törnwall J; Hukkanen M; Nordström DC; Konttinen YT
Acta Ophthalmol Scand; 2004 Oct; 82(5):569-73. PubMed ID: 15453855
[TBL] [Abstract][Full Text] [Related]
9. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease.
Gao J; Killedar S; Cornelius JG; Nguyen C; Cha S; Peck AB
J Autoimmun; 2006 Mar; 26(2):90-103. PubMed ID: 16413168
[TBL] [Abstract][Full Text] [Related]
10. The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
Jonsson R; Vogelsang P; Volchenkov R; Espinosa A; Wahren-Herlenius M; Appel S
Immunol Lett; 2011 Dec; 141(1):1-9. PubMed ID: 21777618
[TBL] [Abstract][Full Text] [Related]
11. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
[TBL] [Abstract][Full Text] [Related]
12. P2Y2 nucleotide receptor up-regulation in submandibular gland cells from the NOD.B10 mouse model of Sjögren's syndrome.
Schrader AM; Camden JM; Weisman GA
Arch Oral Biol; 2005 Jun; 50(6):533-40. PubMed ID: 15848146
[TBL] [Abstract][Full Text] [Related]
13. A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse.
Cha S; Brayer J; Gao J; Brown V; Killedar S; Yasunari U; Peck AB
Scand J Immunol; 2004 Dec; 60(6):552-65. PubMed ID: 15584966
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune Sjögren's-like lesions in salivary glands of TGF-beta1-deficient mice are inhibited by adhesion-blocking peptides.
McCartney-Francis NL; Mizel DE; Redman RS; Frazier-Jessen M; Panek RB; Kulkarni AB; Ward JM; McCarthy JB; Wahl SM
J Immunol; 1996 Aug; 157(3):1306-12. PubMed ID: 8757639
[TBL] [Abstract][Full Text] [Related]
15. Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren's syndrome-like autoimmune exocrinopathy.
Brayer J; Lowry J; Cha S; Robinson CP; Yamachika S; Peck AB; Humphreys-Beher MG
J Rheumatol; 2000 Aug; 27(8):1896-904. PubMed ID: 10955330
[TBL] [Abstract][Full Text] [Related]
16. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
[TBL] [Abstract][Full Text] [Related]
17. New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model.
Humphreys-Beher MG; Peck AB
Arch Oral Biol; 1999 May; 44 Suppl 1():S21-5. PubMed ID: 10414851
[TBL] [Abstract][Full Text] [Related]
18. A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice.
Haneji N; Hamano H; Yanagi K; Hayashi Y
J Immunol; 1994 Sep; 153(6):2769-77. PubMed ID: 8077681
[TBL] [Abstract][Full Text] [Related]
19. Elevated proapoptotic Bax and caspase 3 activation in the NOD.scid model of Sjögren's syndrome.
Masago R; Aiba-Masago S; Talal N; Zuluaga FJ; Al-Hashimi I; Moody M; Lau CA; Peck AB; Brayer J; Humphreys-Beher MG; Dang H
Arthritis Rheum; 2001 Mar; 44(3):693-702. PubMed ID: 11263785
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis and Sjögren syndrome.
Manganelli P; Fietta P
Semin Arthritis Rheum; 2003 Aug; 33(1):49-65. PubMed ID: 12920696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
